{"count":221272,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1214","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1212","results":[{"created":"2021-09-10T18:09:29.605698+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.101","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: KIF23 were changed from Enzyme Disorder; Anaemia, dyserythropoietic congenital, type III; Congenital dyserythropoietic anemia (CDA); Congenital dyserythropoietic anemia type III; 605064 Congenital dyserythropoietic anaemia type 3; CDA III to Congenital dyserythropoietic anemia type III","entity_name":"KIF23","entity_type":"gene"},{"created":"2021-09-10T18:09:18.247820+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.100","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: KIF23 as Red List (low evidence)","entity_name":"KIF23","entity_type":"gene"},{"created":"2021-09-10T18:09:18.232322+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.100","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kif23 has been classified as Red List (Low Evidence).","entity_name":"KIF23","entity_type":"gene"},{"created":"2021-09-10T18:08:01.609828+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4115","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MTRR as ready","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:08:01.596046+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4115","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mtrr has been classified as Green List (High Evidence).","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:07:58.184194+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4115","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MTRR were changed from  to Homocystinuria-megaloblastic anaemia, cbl E type, MIM# 236270","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:07:30.620979+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4114","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MTRR were set to ","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:06:54.368854+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4113","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MTRR was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:06:26.618446+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4112","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MTRR: Rating: GREEN; Mode of pathogenicity: None; Publications: 12555939, 15714522; Phenotypes: Homocystinuria-megaloblastic anaemia, cbl E type, MIM# 236270; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:05:19.502875+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9137","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MTRR as ready","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:05:19.491606+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9137","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mtrr has been classified as Green List (High Evidence).","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:05:12.734980+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9137","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MTRR were changed from  to Homocystinuria-megaloblastic anaemia, cbl E type, MIM# 236270","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:02:57.846399+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9136","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MTRR were set to ","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:02:38.531980+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9135","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MTRR was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:02:22.598005+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9134","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MTRR: Rating: GREEN; Mode of pathogenicity: None; Publications: 12555939, 15714522; Phenotypes: Homocystinuria-megaloblastic anaemia, cbl E type, MIM# 236270; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:01:32.464204+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.99","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MTRR as ready","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:01:32.444532+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.99","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mtrr has been classified as Green List (High Evidence).","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:01:30.189978+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.99","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MTRR were changed from Homocystinuria-megaloblastic anemia, cbl E type, 236270; 236270 Homocystinuria-megaloblastic anemia, cbl E type to Homocystinuria-megaloblastic anaemia, cbl E type, MIM# 236270","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T18:01:12.875792+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.98","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MTRR: Rating: GREEN; Mode of pathogenicity: None; Publications: 12555939, 15714522; Phenotypes: Homocystinuria-megaloblastic anaemia, cbl E type, MIM# 236270; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MTRR","entity_type":"gene"},{"created":"2021-09-10T17:58:59.383129+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4112","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MTR as ready","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T17:58:59.372537+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4112","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mtr has been classified as Green List (High Evidence).","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T17:58:55.499548+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4112","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MTR were changed from  to Homocystinuria-megaloblastic anaemia, cblG complementation type, MIM# 250940","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T17:58:26.849545+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4111","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MTR were set to ","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T17:57:58.685620+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4110","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MTR was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T17:57:20.129687+10:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4109","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MTR: Rating: GREEN; Mode of pathogenicity: None; Publications: 8968736, 8968737, 9683607, 12068375; Phenotypes: Homocystinuria-megaloblastic anaemia, cblG complementation type, MIM# 250940; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T17:56:46.269747+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9134","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MTR as ready","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T17:56:46.257200+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9134","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mtr has been classified as Green List (High Evidence).","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T17:56:39.065119+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9134","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MTR were changed from  to Homocystinuria-megaloblastic anaemia, cblG complementation type, MIM# 250940","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T17:56:22.283322+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9133","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MTR were set to ","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T17:55:46.300154+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9132","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MTR was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T17:55:28.223960+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9131","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MTR: Rating: GREEN; Mode of pathogenicity: None; Publications: 8968736, 8968737, 9683607, 12068375; Phenotypes: Homocystinuria-megaloblastic anaemia, cblG complementation type, MIM# 250940; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T16:28:57.217416+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.98","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MTR as ready","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T16:28:57.198949+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.98","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mtr has been classified as Green List (High Evidence).","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T16:28:55.364092+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.98","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MTR were changed from Homocystinuria-megaloblastic anemia, cblG complementation type, 250940; 250940 Homocystinuria-megaloblastic anemia, cblG complementation type to Homocystinuria-megaloblastic anaemia, cblG complementation type, MIM# 250940","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T16:28:46.166643+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.97","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MTR were set to 9683607; 12068375","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T16:28:31.096527+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.96","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MTR: Rating: GREEN; Mode of pathogenicity: None; Publications: 8968736, 8968737, 9683607, 12068375; Phenotypes: Homocystinuria-megaloblastic anaemia, cblG complementation type, MIM# 250940; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MTR","entity_type":"gene"},{"created":"2021-09-10T16:12:02.823376+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.121","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LPIN2 as ready","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:12:02.810324+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.121","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lpin2 has been classified as Green List (High Evidence).","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:11:33.011020+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.121","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LPIN2 were changed from  to Majeed syndrome, MIM# 609628; Chronic recurrent multifocal osteomyelitis with congenital dyserythropoietic anaemia","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:11:01.684659+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.120","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: LPIN2 were set to ","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:10:26.070074+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.119","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LPIN2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:09:34.213883+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.118","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: LPIN2: Rating: GREEN; Mode of pathogenicity: None; Publications: 15994876, 33993107, 33670882, 33314777, 31727123; Phenotypes: Majeed syndrome, MIM# 609628, Chronic recurrent multifocal osteomyelitis with congenital dyserythropoietic anaemia; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:04:49.022643+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9131","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LPIN2 as ready","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:04:49.007576+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9131","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lpin2 has been classified as Green List (High Evidence).","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:03:18.111565+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9131","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LPIN2 were changed from  to Majeed syndrome, MIM# 609628; Chronic recurrent multifocal osteomyelitis with congenital dyserythropoietic anaemia","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:02:58.045367+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9130","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: LPIN2 were set to ","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:02:39.807055+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9129","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LPIN2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:02:23.295347+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.9128","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: LPIN2: Rating: GREEN; Mode of pathogenicity: None; Publications: 15994876, 33993107, 33670882, 33314777, 31727123; Phenotypes: Majeed syndrome, MIM# 609628, Chronic recurrent multifocal osteomyelitis with congenital dyserythropoietic anaemia; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:01:45.244246+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.96","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LPIN2 as ready","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:01:45.234752+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.96","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lpin2 has been classified as Green List (High Evidence).","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:01:43.227043+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.96","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LPIN2 were changed from Congenital dyserythropoietic anemia; Microcytic anemia; Majeed syndrome, 609628; 609628 Microcytic anemia; CDA; Majeed syndrome; 609628 Majeed syndrome to Majeed syndrome, MIM# 609628; Chronic recurrent multifocal osteomyelitis with congenital dyserythropoietic anaemia","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:01:32.077088+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.95","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: LPIN2 were set to 17330256; 15994876","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T16:01:18.115347+10:00","panel_name":"Red cell disorders","panel_id":3366,"panel_version":"0.94","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: LPIN2: Rating: GREEN; Mode of pathogenicity: None; Publications: 15994876, 33993107, 33670882, 33314777, 31727123; Phenotypes: Majeed syndrome, MIM# 609628, Chronic recurrent multifocal osteomyelitis with congenital dyserythropoietic anaemia; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"LPIN2","entity_type":"gene"},{"created":"2021-09-10T14:31:39.531898+10:00","panel_name":"Hydrops fetalis","panel_id":116,"panel_version":"0.206","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: KCNQ1 as ready","entity_name":"KCNQ1","entity_type":"gene"},{"created":"2021-09-10T14:31:39.522780+10:00","panel_name":"Hydrops fetalis","panel_id":116,"panel_version":"0.206","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kcnq1 has been classified as Red List (Low Evidence).","entity_name":"KCNQ1","entity_type":"gene"},{"created":"2021-09-10T14:27:30.387213+10:00","panel_name":"Hydrops fetalis","panel_id":116,"panel_version":"0.206","user_name":"Zornitza Stark","item_type":"entity","text":"gene: KCNQ1 was added\ngene: KCNQ1 was added to Hydrops fetalis. Sources: Expert Review\nMode of inheritance for gene: KCNQ1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: KCNQ1 were set to 27539165\nPhenotypes for gene: KCNQ1 were set to Long QT syndrome 1, 192500\nReview for gene: KCNQ1 was set to RED\nAdded comment: Can present antenatally with bradycardia, but no specific mention of hydrops. \nSources: Expert Review","entity_name":"KCNQ1","entity_type":"gene"},{"created":"2021-09-10T14:26:00.506290+10:00","panel_name":"Hydrops fetalis","panel_id":116,"panel_version":"0.205","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: KCNH2 as ready","entity_name":"KCNH2","entity_type":"gene"},{"created":"2021-09-10T14:26:00.493443+10:00","panel_name":"Hydrops fetalis","panel_id":116,"panel_version":"0.205","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: kcnh2 has been classified as Red List (Low Evidence).","entity_name":"KCNH2","entity_type":"gene"},{"created":"2021-09-10T14:25:53.727487+10:00","panel_name":"Hydrops fetalis","panel_id":116,"panel_version":"0.205","user_name":"Zornitza Stark","item_type":"entity","text":"gene: KCNH2 was added\ngene: KCNH2 was added to Hydrops fetalis. Sources: Expert Review\nMode of inheritance for gene: KCNH2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: KCNH2 were set to 27492745\nPhenotypes for gene: KCNH2 were set to long QT syndrome\nReview for gene: KCNH2 was set to RED\nAdded comment: Single case report identified of presentation with hydrops. \nSources: Expert Review","entity_name":"KCNH2","entity_type":"gene"},{"created":"2021-09-10T14:20:56.947344+10:00","panel_name":"Hydrops fetalis","panel_id":116,"panel_version":"0.204","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SCN5A as ready","entity_name":"SCN5A","entity_type":"gene"},{"created":"2021-09-10T14:20:56.936256+10:00","panel_name":"Hydrops fetalis","panel_id":116,"panel_version":"0.204","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: scn5a has been classified as Green List (High Evidence).","entity_name":"SCN5A","entity_type":"gene"},{"created":"2021-09-10T14:20:41.512708+10:00","panel_name":"Hydrops fetalis","panel_id":116,"panel_version":"0.204","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: SCN5A as Green List (high evidence)","entity_name":"SCN5A","entity_type":"gene"},{"created":"2021-09-10T14:20:41.501855+10:00","panel_name":"Hydrops fetalis","panel_id":116,"panel_version":"0.204","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: scn5a has been classified as Green List (High Evidence).","entity_name":"SCN5A","entity_type":"gene"},{"created":"2021-09-10T14:20:13.021697+10:00","panel_name":"Hydrops fetalis","panel_id":116,"panel_version":"0.203","user_name":"Zornitza Stark","item_type":"entity","text":"gene: SCN5A was added\ngene: SCN5A was added to Hydrops fetalis. Sources: Expert Review\nMode of inheritance for gene: SCN5A was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: SCN5A were set to 22064211; 15184283; 19419784\nPhenotypes for gene: SCN5A were set to Long QT syndrome 3 (MIM#603830)\nReview for gene: SCN5A was set to GREEN\nAdded comment: Three families reported with severe perinatal presentation, including hydrops. \nSources: Expert Review","entity_name":"SCN5A","entity_type":"gene"},{"created":"2021-09-10T10:53:24.431899+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.147","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: OPDM1.","entity_name":"OPDM1","entity_type":"str"},{"created":"2021-09-10T10:52:42.990770+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.147","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: NIID.","entity_name":"NIID","entity_type":"str"},{"created":"2021-09-10T10:51:58.513865+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.147","user_name":"Zornitza Stark","item_type":"panel","text":"Panel types changed to Australian Genomics; Royal Melbourne Hospital; Rare Disease","entity_name":null,"entity_type":null},{"created":"2021-09-10T10:51:29.870047+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag paediatric-onset tag was added to STR: VACTERLX.","entity_name":"VACTERLX","entity_type":"str"},{"created":"2021-09-10T10:50:59.144823+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: OPML1.","entity_name":"OPML1","entity_type":"str"},{"created":"2021-09-10T10:48:49.710249+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Marked STR: NIPA1 as ready","entity_name":"NIPA1","entity_type":"str"},{"created":"2021-09-10T10:48:49.700003+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Str: nipa1 has been classified as Red List (Low Evidence).","entity_name":"NIPA1","entity_type":"str"},{"created":"2021-09-10T10:48:44.969603+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: NIPA1.","entity_name":"NIPA1","entity_type":"str"},{"created":"2021-09-10T10:48:13.055751+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag paediatric-onset tag was added to STR: FRAXF.","entity_name":"FRAXF","entity_type":"str"},{"created":"2021-09-10T10:47:10.877514+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag paediatric-onset tag was added to STR: FRA7A.","entity_name":"FRA7A","entity_type":"str"},{"created":"2021-09-10T10:45:05.560515+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Marked STR: FRA11B as ready","entity_name":"FRA11B","entity_type":"str"},{"created":"2021-09-10T10:45:05.551332+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Str: fra11b has been classified as Red List (Low Evidence).","entity_name":"FRA11B","entity_type":"str"},{"created":"2021-09-10T10:44:58.966578+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag paediatric-onset tag was added to STR: FRA11B.","entity_name":"FRA11B","entity_type":"str"},{"created":"2021-09-10T10:43:56.676689+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag paediatric-onset tag was added to STR: FRA11A.","entity_name":"FRA11A","entity_type":"str"},{"created":"2021-09-10T10:43:36.327126+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: FAME7.","entity_name":"FAME7","entity_type":"str"},{"created":"2021-09-10T10:43:22.408584+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: FAME6.","entity_name":"FAME6","entity_type":"str"},{"created":"2021-09-10T10:43:05.407644+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: FAME4.","entity_name":"FAME4","entity_type":"str"},{"created":"2021-09-10T10:41:43.323498+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: DMD.\nTag paediatric-onset tag was added to STR: DMD.","entity_name":"DMD","entity_type":"str"},{"created":"2021-09-10T10:41:25.525126+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag paediatric-onset tag was added to STR: FRA2A.","entity_name":"FRA2A","entity_type":"str"},{"created":"2021-09-10T10:40:54.336272+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag paediatric-onset tag was added to STR: FRA12A.","entity_name":"FRA12A","entity_type":"str"},{"created":"2021-09-10T10:40:15.875004+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Marked STR: CCD as ready","entity_name":"CCD","entity_type":"str"},{"created":"2021-09-10T10:40:15.864472+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Str: ccd has been classified as Amber List (Moderate Evidence).","entity_name":"CCD","entity_type":"str"},{"created":"2021-09-10T10:40:12.733881+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag paediatric-onset tag was added to STR: CCD.","entity_name":"CCD","entity_type":"str"},{"created":"2021-09-10T10:39:52.968809+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Marked STR: CANVAS_ACAGG as ready","entity_name":"CANVAS_ACAGG","entity_type":"str"},{"created":"2021-09-10T10:39:52.956613+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Str: canvas_acagg has been classified as Amber List (Moderate Evidence).","entity_name":"CANVAS_ACAGG","entity_type":"str"},{"created":"2021-09-10T10:39:36.888143+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: CANVAS_ACAGG.","entity_name":"CANVAS_ACAGG","entity_type":"str"},{"created":"2021-09-10T10:39:05.623326+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: XDP.","entity_name":"XDP","entity_type":"str"},{"created":"2021-09-10T10:37:34.332975+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag paediatric-onset tag was added to STR: TOF.","entity_name":"TOF","entity_type":"str"},{"created":"2021-09-10T10:37:09.497135+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag paediatric-onset tag was added to STR: SPD1.","entity_name":"SPD1","entity_type":"str"},{"created":"2021-09-10T10:36:42.744018+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: SCA8.","entity_name":"SCA8","entity_type":"str"},{"created":"2021-09-10T10:35:58.635017+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: SCA7.","entity_name":"SCA7","entity_type":"str"},{"created":"2021-09-10T10:35:07.307481+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: SCA6.","entity_name":"SCA6","entity_type":"str"},{"created":"2021-09-10T10:33:58.713440+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: SCA37.","entity_name":"SCA37","entity_type":"str"},{"created":"2021-09-10T10:33:36.081822+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: SCA36.","entity_name":"SCA36","entity_type":"str"},{"created":"2021-09-10T10:33:11.985670+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: SCA31.","entity_name":"SCA31","entity_type":"str"},{"created":"2021-09-10T10:32:18.017982+10:00","panel_name":"Repeat Disorders","panel_id":3597,"panel_version":"0.146","user_name":"Zornitza Stark","item_type":"entity","text":"Tag adult-onset tag was added to STR: SCA3.\nTag paediatric-onset tag was added to STR: SCA3.","entity_name":"SCA3","entity_type":"str"}]}